- Home
- VANI vs DALN Comparison
VANI vs DALN Comparison
Compare VANI & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- DALN
- Stock Information
- Founded
- VANI 1998
- DALN 1954
- Country
- VANI United States
- DALN United States
- Employees
- VANI N/A
- DALN N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DALN Newspapers/Magazines
- Sector
- VANI Health Care
- DALN Consumer Discretionary
- Exchange
- VANI Nasdaq
- DALN Nasdaq
- Market Cap
- VANI 88.3M
- DALN 73.2M
- IPO Year
- VANI 2014
- DALN 2008
- Fundamental
- Price
- VANI $1.33
- DALN $14.86
- Analyst Decision
- VANI Strong Buy
- DALN
- Analyst Count
- VANI 1
- DALN 0
- Target Price
- VANI $4.00
- DALN N/A
- AVG Volume (30 Days)
- VANI 121.4K
- DALN 378.9K
- Earning Date
- VANI 08-12-2025
- DALN 07-30-2025
- Dividend Yield
- VANI N/A
- DALN N/A
- EPS Growth
- VANI N/A
- DALN N/A
- EPS
- VANI N/A
- DALN N/A
- Revenue
- VANI N/A
- DALN $121,119,000.00
- Revenue This Year
- VANI N/A
- DALN N/A
- Revenue Next Year
- VANI N/A
- DALN N/A
- P/E Ratio
- VANI N/A
- DALN N/A
- Revenue Growth
- VANI N/A
- DALN N/A
- 52 Week Low
- VANI $0.91
- DALN $3.66
- 52 Week High
- VANI $1.80
- DALN $16.10
- Technical
- Relative Strength Index (RSI)
- VANI 40.85
- DALN 80.32
- Support Level
- VANI $1.53
- DALN $14.79
- Resistance Level
- VANI $1.64
- DALN $16.10
- Average True Range (ATR)
- VANI 0.09
- DALN 0.19
- MACD
- VANI -0.03
- DALN -0.13
- Stochastic Oscillator
- VANI 7.44
- DALN 49.80
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company. It operates The Dallas Morning News (dallasnews.com), Texas' newspaper. These operations generate revenue from advertising sales within the company's newspaper and digital platforms, subscriptions and retail sales of its newspaper, and commercial printing and distribution services predominantly related to national newspapers. In addition to traditional print and digital advertising, the company has a full-service agency, Medium Giant, offering businesses comprehensive, strategic, and creative marketing solutions. The company's two reportable segments are TDMN and Agency. Maximum revenue is derived from the TDMN segment, which comprises its traditional print business. The firm's customer base is concentrated in North Texas.